Stay updated on IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.

Latest updates to the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, representing a minor metadata update rather than substantive changes to the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now indicates that recruitment is closed, while new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting updated alongside related topics and a revision note.SummaryDifference0.7%

- Check23 days agoChange DetectedA new revision label Revision: v3.5.5 appears on the page, and several related topics items are removed from the related topics area (including Ovarian cancer and MedlinePlus Genetics), along with the Related topics heading.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now shows Revision: v3.5.4 instead of v3.5.3, indicating a software/content update to the page. This update does not alter the study details or results.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page gains additional related topics metadata, including 'Ovarian cancer' and 'MedlinePlus Genetics', linking the study to broader disease- and genetics-related resources.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page's disease tagging has been reduced by removing the 'Ovarian cancer' keyword and the 'MedlinePlus Genetics' related topics entry, affecting how the study is categorized and linked to related resources.SummaryDifference0.2%

Stay in the know with updates to IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IP Nivolumab Tolerance in Ovarian Cancer Clinical Trial page.